PC
BSX icon

Promus Capital’s Boston Scientific BSX Stock Holding History

Promus Capital’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$13K Hold
133
– – 0.01% 243
2025
Q2 		$14.3K Hold
133
– – 0.01% 245
2025
Q1 		$13.4K Hold
133
– – 0.01% 239
2024
Q4 		$11.9K Buy
+133
New +$11.7K 0.01% 236

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Promus Capital's BSX Position: Q3 2025 in Review

Promus Capital held its Boston Scientific (BSX) position steady in Q3 2025 at 133 shares worth $13K. The position accounts for 0.01% of the portfolio, ranked #243.

Promus Capital first reported a position in BSX in Q4 2024 and has held it in 4 quarters since. The position peaked at $14.3K in Q2 2025. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

  • Promus Capital held 133 shares of Boston Scientific worth $13K as of Q3 2025.
  • Promus Capital left its Boston Scientific share count unchanged in Q3 2025.
  • Boston Scientific made up 0.01% of Promus Capital's portfolio in Q3 2025, its #243 holding.
  • Promus Capital first reported a position in Boston Scientific in Q4 2024 and has held it in 4 quarters since.
  • Promus Capital's Boston Scientific position peaked at $14.3K in Q2 2025.
  • 1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on Promus Capital's 13F filing for Q3 2025, filed 13 Nov 2025.